TCL Archive Q & A: NCI’s Doroshow Says Phase I Program Will Stress Correlative Studies for Small Biotech Firms April 6, 2012
TCL Archive “Spoiled, Petulant Brat”: BioMarin CEO Fires Off Feisty Emails In Battle Over Access to PARP Inhibitor November 8, 2013
TCL Archive In Brief: New NIH Grant Program Offers Up To $1 Million a Year For Centers At Minority Institutions January 25, 1985
TCL Archive Neoadjuvant Surgery Makes Radiation Unnecessary In Some Early Breast Cancer September 26, 2008
